Radioembolization for hepatocellular carcinoma using TheraSphere®
The Saudi Journal of Gastroenterology, 2011 Background/Aim: Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Radioembolization with yttrium-90 (Y90) microspheres is a new concept in radiation therapy for HCC.
Safiyya Mohamed Ali
doaj +4 more sources
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma [PDF]
Frontiers in Oncology, 2022 AimsTo perform a cost-effectiveness analysis (CEA) comparing personalised dosimetry with standard dosimetry in the context of selective internal radiation therapy (SIRT) with TheraSphere for the management of adult patients with locally advanced ...
Carla Rognoni +25 more
doaj +6 more sources
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis [PDF]
Hpb, 2012 Neuroendocrine tumours (NET) frequently metastasize to the liver. NET liver metastasis has been shown to respond to Yttrium-90 microspheres therapy. The aims of the present study were to define factors that predict the response to radio-embolization in patients with NET liver metastases.From January 2006 until March 2009, all patients with NET liver ...
Mazen Hassanain +2 more
exaly +5 more sources
Technology in Cancer Research and Treatment, 2009 This retrospective study was undertaken to obtain information regarding the survival and toxicities after Yttrium-90 microspheres treatment in patients with primary liver malignancies. Baseline, treatment, and follow-up data were collected and analyzed for 21 patients treated with Yttrium-90 microspheres. Survival analysis was then performed.
Klaus D Hagspiel +2 more
exaly +5 more sources
Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization [PDF]
Pharmaceuticals, 2023 Hepatocellular carcinoma (HCC) is one of the most common neoplasms worldwide and the third most common cause of cancer-related death. Several liver-targeted intra-arterial therapies are available for unresectable HCC, including selective internal ...
Salma Binzaqr +6 more
doaj +2 more sources
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patientsResearch in context [PDF]
EClinicalMedicineSummary: Background: Selective Internal Radiation Therapy with yttrium-90 (Y90) has been used for decades, yet guideline recommendations remain inconsistent. High-quality real-world data is needed to guide practice.
Boris Guiu +147 more
doaj +2 more sources
Diagnostics, 2021 Liver tumors are common and may be unamenable to surgery or ablative treatments. Consequently, other treatments have been devised. To assess the safety and efficacy of transarterial radioembolization (TARE) with Yttrium-90 for hepatocellular carcinoma ...
Julie Pellegrinelli +13 more
doaj +2 more sources
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients [PDF]
Liver Transplantation, 2004 Hepatocellular carcinoma (HCC) generally arises in a cirrhotic liver and, in most cases, is multifocal and bilobar. Although trans-hepatic artery chemoembolization (TACE) can be highly affective in shrinking tumors, it is limited by virtue of the damage that it can cause to the liver that is already damaged by chronic disease.
Brian I. Carr
exaly +3 more sources
Outcomes of therasphere radioembolization for colorectal metastases and hepatocellular cancer: A single center experience [PDF]
Hpb, 2016 I Parmentier, A Maes
exaly +2 more sources
Use of X-Ray Fluorescence Microscopy for Studies on Research Models of Hepatocellular Carcinoma
Frontiers in Public Health, 2021 Introduction: TheraSphere® microspheres containing yttrium 90Y are among many radioembolization agents used clinically to reduce liver tumor burden, and their effects on cancer volume reduction are well-established.
Tatjana Paunesku +11 more
doaj +1 more source